BHVN (STOCKS)
Biohaven Ltd.
$11.800000
-0.400000 (-3.28%)
Prev close: $12.200000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Vladimir Coric
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,798.79M
- Employees
- 256
- P/E (TTM)
- -1.55
- P/B (TTM)
- -72.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
10
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.64 | $-1.93 | +0.2902 | +15.03% |
|
Jun 2025 (Q2)
|
$-1.94 | $-1.93 | -0.0107 | -0.55% |
|
Mar 2025 (Q1)
|
$-2.17 | $-1.73 | -0.4414 | -25.54% |
|
Dec 2024 (Q4)
|
$-1.85 | $-1.60 | -0.2466 | -15.38% |
Financial Statements
| Revenues | $859.68M |
| Benefits Costs and Expenses | $1.77B |
| Cost Of Revenue | $123.55M |
| Costs And Expenses | $1.58B |
| Gross Profit | $736.14M |
| Nonoperating Income/Loss | -$269.50M |
| Operating Expenses | $1.38B |
| Selling, General, and Administrative Expenses | $861.67M |
| Research and Development | $514.38M |
| Operating Income/Loss | -$639.91M |
| Income/Loss From Continuing Operations After Tax | -$930.69M |
| Income/Loss From Continuing Operations Before Tax | -$909.41M |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | $21.29M |
| Net Income/Loss | -$930.69M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$1.91M |
| Net Income/Loss Attributable To Parent | -$1.02B |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.02B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$14.83 |
| Diluted Earnings Per Share | -$14.83 |
| Basic Average Shares | 136,564,256 |
| Diluted Average Shares | 136,564,256 |
| Assets | $1.39B |
| Current Assets | $1.17B |
| Inventory | $106.56M |
| Prepaid Expenses | $100.36M |
| Other Current Assets | $967.42M |
| Noncurrent Assets | $211.91M |
| Fixed Assets | $15.73M |
| Intangible Assets | $75.11M |
| Other Non-current Assets | $121.07M |
| Liabilities | $2.19B |
| Current Liabilities | $671.96M |
| Accounts Payable | $64.15M |
| Wages | $35.92M |
| Other Current Liabilities | $571.89M |
| Noncurrent Liabilities | $1.52B |
| Long-term Debt | $764.98M |
| Other Non-current Liabilities | $754.87M |
| Redeemable Noncontrolling Interest | $0.00 |
| Equity | -$805.56M |
| Equity Attributable To Noncontrolling Interest | -$4.63M |
| Equity Attributable To Parent | -$800.93M |
| Temporary Equity | $0.00 |
| Liabilities And Equity | $1.39B |
| Net Cash Flow From Operating Activities | -$556.06M |
| Net Cash Flow From Operating Activities, Continuing | -$556.06M |
| Net Cash Flow From Investing Activities | -$321.39M |
| Net Cash Flow From Investing Activities, Continuing | -$321.39M |
| Net Cash Flow From Financing Activities | $808.58M |
| Net Cash Flow From Financing Activities, Continuing | $808.58M |
| Exchange Gains/Losses | -$2.72M |
| Net Cash Flow | -$71.59M |
| Net Cash Flow, Continuing | -$68.87M |
| Comprehensive Income/Loss | -$936.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$1.91M |
| Comprehensive Income/Loss Attributable To Parent | -$934.88M |
| Other Comprehensive Income/Loss | -$6.09M |